Diagnosis and treatment of vasculitis
European Journal of Neurology
; 29:26, 2022.
Article
in English
| EMBASE | ID: covidwho-1978444
ABSTRACT
Primary angiitis of the central nervous system (PACNS) is an inflammatory disease affecting exclusively small and medium-sized vessels of the central nervous system. CNSvasculitis may also occur in systemic diseases like giant cell arteritis, Takayasu arteritis, granulomatosis with polyangiitis, or Behçet syndrome. The most common presenting symptoms of CNS vasculitis are multifocal symptoms associated with recurrent episodes of ischemia or hemorrhage, encephalopathy-related cognitive and affective abnormalities, and headaches. Diagnostic work up of CNS vasculitis includes MRI, CSF examination, digital subtraction angiography and brain biopsy. High-resolution, contrast-enhanced, compensated and fat-saturated MRI imaging of the cerebral vessel walls (black-blood imaging) may be of some value for the detection of CNS-vasculitis. Patients with normal CSF findings are unlikely to have CNS vasculitis. Brain biopsy should be performed in suspected PACNS. Important differential diagnoses include reversible cerebral vasoconstriction syndrome, moyamoya angiopathy and infectious vasculopathies (VZV, SarsCoV2, borreliosis, bacterial endocarditis). The adherence to diagnostic criteria and the avoidance of inappropriate therapies are essential. Treatment recommendations for CNS-vasculitis include glucocorticoids in combination with cyclophosphamide or rituximab;however, randomized clinical trials of PACNS treatment do not exist. Induction therapy is recommended for 6 to 12 months. After remission is achieved, treatment may be continued with substances as mycophenolate mofetil, methotrexate, or azathioprine. Repeated clinical, CSF- and neuroradiological monitoring is needed to determine the individual duration of maintenance therapy.
azathioprine; cyclophosphamide; glucocorticoid; methotrexate; mycophenolate mofetil; rituximab; adult; aortic arch syndrome; avoidance behavior; bacterial endocarditis; bleeding; Borrelia infection; brain biopsy; brain blood vessel; brain disease; central nervous system; cerebrospinal fluid; conference abstract; contrast enhancement; controlled study; diagnosis; differential diagnosis; digital subtraction angiography; drug combination; drug therapy; giant cell arteritis; headache; human; maintenance therapy; moyamoya disease; nonhuman; nuclear magnetic resonance imaging; primary central nervous system vasculitis; randomized controlled trial (topic); remission; reversible cerebral vasoconstriction syndrome; systemic disease; Varicella zoster virus; vascular disease; vasculitis; Wegener granulomatosis
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Language:
English
Journal:
European Journal of Neurology
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS